Effectiveness and Safety of Valtoco® (NRL-1; diazepam nasal spray) in Patients With Epilepsy and a History of Seasonal Allergies: Interim Results From a Phase 3, Open-Label, 12-Month Repeat Dose Study (2048)
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.94.15_supplement.2048